13 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Early Prevention of Diabetes Complications in people with Hyperglycaemia in Europe (E-PREDICE)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2017,
"Background: A significant proportion of pre-diabetics, show macro and micro vascular complications associated with hyperglycaemia. Although many trials have demonstrated the efficacy of lifestyle and pharmaceutical interventions in diabetes prevention, no trial has evaluated the extent to which mid- and long-term complications can be prevented by early interventions on hyperglycaemia.Aims: To ass ...
Voir le projet
37
Participants partenaires
TERMINÉ
EUROPEAN FORENSIC GENETICS Network of Excellence (EUROFORGEN-NOE)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2016,
The EUROFORGEN-NoE proposal aims to develop a network of excellence for the creation of a European Virtual Centre of Forensic Genetic Research. Forensic genetics is a highly innovative field of applied science with a strong impact on the security of citizens. However, the genetic methods to identify offenders as well as the creation of national DNA databases have caused concerns to the possible vi ...
Voir le projet
19
Participants partenaires
TERMINÉ
Biodegradable Magnetic Stent for Coronary Artery Luminal Regeneration (BIOMAGSCAR)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2016,
By 2010 1.5 million stents per year will be deployed in Europe. Although outcome for patients has improved, stents still fail because of the occurrence of restenosis and thrombosis at the site of implantation. While drug eluting stents have helped to reduce the problem of restenosis, neointimal proliferation causing restenosis can still occur. Additional concerns exist regarding drug eluting stent ...
Voir le projet
8
Participants partenaires
TERMINÉ
A BLUEPRINT of Haematopoietic Epigenomes (BLUEPRINT)
Date du début: 1 oct. 2011, Date de fin: 30 sept. 2016,
In response to the call for a high impact initiative on the human epigenome, the BLUEPRINT Consortium has been formed with the aim of generating at least 100 reference epigenomes and studying them to advance and exploit knowledge of the underlying biological processes and mechanisms in health and disease. BLUEPRINT will focus on distinct types of haematopoietic cells from healthy individuals and o ...
Voir le projet
45
Participants partenaires
TERMINÉ
More Medicines for Tuberculosis (MM4TB)
Date du début: 1 févr. 2011, Date de fin: 31 juil. 2016,
The More Medicines for Tuberculosis (MM4TB) consortium evolved from the highly successful FP6 project, New Medicines for TB (NM4TB), that delivered a candidate drug for clinical development two years ahead of schedule. Building on these firm foundations and exploiting its proprietary pharmacophores, MM4TB will continue to develop new drugs for TB treatment. An integrated approach will be impleme ...
Voir le projet
27
Participants partenaires
TERMINÉ
AIP gene regulation and its implications in pituitary tumorigenesis (REGAIP)
Date du début: 1 mai 2013, Date de fin: 30 avr. 2015,
"Background: Pituitary adenomas are a public health problem, due to their prevalence, morbidity and medical costs. AIP is a tumor suppressor gene that was recently linked to pituitary tumors in up to 30% of the familial isolated pituitary adenoma syndrome (FIPA) families, an autosomal dominant disease with incomplete penetrance. AIP mutation-positive patients are younger (children/young adults), h ...
Voir le projet
1
Participant partenaire
TERMINÉ
EUROmediCAT: Safety of Medication use in Pregnancy in Relation to Risk of Congenital Malformations (EUROMEDICAT)
Date du début: 1 mars 2011, Date de fin: 28 févr. 2015,
A variety of complementary approaches are needed to evaluate safety of medicine use in pregnancy. To evaluate safety in relation to teratogenicity (capacity to cause malformations), population-based congenital anomaly registers, which are already networked across Europe (EUROCAT) with a common database, can provide a cost-effective mechanism which is as yet underexploited. The enormous population ...
Voir le projet
10
Participants partenaires
TERMINÉ
"Evidence-based Medicine COllaboratioN NEtwork for guideline development, teaChing and disseminaTion" (EBM CONNECT)
Date du début: 15 oct. 2010, Date de fin: 14 oct. 2014,
"EBM CONNECT aims to harness the combined research expertise of several centres in evidence-based medicine or EBM. We will focus on development of state-of-the-art methodology for systematic reviews and practice guidelines in maternal health. These will be employed for improving research skills throughout the European Union and the developing world and for promoting effective healthcare through re ...
Voir le projet
5
Participants partenaires
TERMINÉ
Molecular Targets Open for Regulation by the gut flora – New Avenues for improved Diet to Optimize European health (TORNADO)
Date du début: 1 sept. 2009, Date de fin: 31 août 2014,
"Europe is facing major diet related health problems. Attitudes to eating habits have to be changed and the benefits of alternative treatment regimes substantiated. This can only be achieved by providing guidelines regulating health claims based on scientific data. Thus, there is a unique opportunity to use gut flora in potential treatment regimes and as a preventive target for major diet related ...
Voir le projet
24
Participants partenaires
TERMINÉ
The anatomical, physiological, and molecular basis of chronic visceral pain in humans (Human visceral pain)
Date du début: 10 mai 2012, Date de fin: 9 mai 2014,
Chronic visceral pain (CVP) is one of the most frequent reasons for seeking health care. Pain can arise from inflammatory disease, but 50% of patients with visceral pain have no diagnostic abnormalities, and are classed as “functional”. Both types of CVP are poorly understood, but animal studies show that they involve hypersensitivity of visceral sensory nerves, and some of the molecular mechanism ...
Voir le projet
1
Participant partenaire
TERMINÉ
Accessing Medicines in Africa and South Asia (AMASA)
Date du début: 1 mai 2010, Date de fin: 31 oct. 2013,
"The main aim of the proposed research is to investigate how the interplay of patent regimes, pharmaceutical regulation, availability of drug production facilities, health care infrastructure and service provision, and engagement by foreign donors influence appropriate, affordable access to medicines in South Asia and Sub-Saharan Africa. We aim to map patterns of production, distribution, supply a ...
Voir le projet
8
Participants partenaires
TERMINÉ
Evaluation of Integrated Cardiac Imaging for the Detection and Characterization of Ischemic Heart Disease (EVINCI-study)
Date du début: 1 janv. 2009, Date de fin: 30 juin 2012,
The main purpose of the EVINCI-study is to test the impact of combined “anatomo-functional” non invasive cardiac imaging for detection and characterization of Ischemic Heart Disease (IHD). The EVINCI-study is a prospective clinical European multicenter trial performed in a cohort of 700 patients with suspected IHD. Patients with intermediate pre-test probability will undergo clinical and biohumora ...
Voir le projet
22
Participants partenaires
TERMINÉ
European Network on Noise And Health (ENNAH)
Date du début: 1 sept. 2009, Date de fin: 31 janv. 2012,
"This proposal puts forward plans to establish a research network of experts on noise and health in Europe. This network will establish future research directions and policy needs in Europe. The network will review the existing literature on environmental noise exposure and health focussing on the consolidation of existing state of the art knowledge and the identification of gaps in the evidence a ...
Voir le projet